Form 4: Guardant Health's Co-CEO Helmy Eltoukhy Reports Stock Transactions
SEC Form 4
Helmy Eltoukhy, Co-CEO of Guardant Health, reports the vesting and subsequent tax withholding of restricted stock units, resulting in adjustments to his beneficial ownership.
Summary
- On March 31, 2025, Helmy Eltoukhy, Co-CEO of Guardant Health, had 4,814 shares of common stock vest from restricted stock units, followed by a tax withholding of 2,440 shares at a price of $42.6.
- On April 1, 2025, an additional 23,998 shares vested, with 12,163 shares withheld for taxes at a price of $42.47.
- Following these transactions, Eltoukhy's directly held beneficial ownership of Guardant Health common stock is 2,409,290 shares.
- He also holds 14,444 restricted stock units from the March 12, 2025 grant and 167,980 restricted stock units from the March 18, 2024 grant.
Sentiment
Score: 5
Explanation: This is a neutral report on stock transactions, with no inherent positive or negative sentiment.
Industry Context
This Form 4 filing is a routine disclosure related to executive compensation and stock ownership, common in publicly traded companies. It provides transparency to investors regarding insider transactions.
Stakeholder Impact
- Shareholders are informed about the Co-CEO's stock transactions, providing transparency into insider activity.
Key Dates
| Date | Description |
|---|---|
| 03/18/2024 | Date of restricted stock unit award that vests over a three-year period. |
| 01/01/2025 | 33% of the shares subject to the March 18, 2024 award vested. |
| 03/12/2025 | Date of restricted stock unit award that vests in four equal installments on the last day of each calendar quarter. |
| 03/31/2025 | Vesting of 4,814 common stock shares and tax withholding of 2,440 shares. |
| 03/31/2025 | First vesting date for the restricted stock unit award granted on March 12, 2025. |
| 04/01/2025 | Vesting of 23,998 common stock shares and tax withholding of 12,163 shares. |
| 04/02/2025 | Date of signature for the Form 4 filing. |
| 06/30/2025 | Second vesting date for the restricted stock unit award granted on March 12, 2025. |
| 09/30/2025 | Third vesting date for the restricted stock unit award granted on March 12, 2025. |
| 12/31/2025 | Fourth vesting date for the restricted stock unit award granted on March 12, 2025. |
Keywords
Guardant Health, Helmy Eltoukhy, Form 4, Stock Transactions, Restricted Stock Units, Beneficial Ownership, Tax Withholding
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.